Prevention of Thrombosis Recurrence in Patients With Low Circulating Levels of Antithrombin.
Condition(s):Venous ThrombosisLast Updated:September 13, 2012Unknown status
Hide Studies Not Open or Pending
Condition(s):Venous ThrombosisLast Updated:September 13, 2012Unknown status
Condition(s):Stroke; PET; ThrombosisLast Updated:April 21, 2023Recruiting
Condition(s):Silent Stroke; Silent Cerebral Infarct; Covert Brain Infarct; Covert Brain Infarction; Lacune; Silent Brain InfarctionLast Updated:January 13, 2023Recruiting
Condition(s):Thoracic Aortic AneurysmsLast Updated:February 8, 2023Recruiting
Condition(s):Phrenic Nerve PalsyLast Updated:January 29, 2021Completed
Condition(s):Acute Stroke; Surgical ProcedureLast Updated:January 3, 2022Unknown status
Condition(s):Cardiovascular Diseases; Adherence, Medication; Medication Adherence; Diabetes Mellitus; Hypertension; Hyperlipidemias; Coronary Artery Disease; Atrial FibrillationLast Updated:December 6, 2023Active, not recruiting
Condition(s):Heart FailureLast Updated:January 30, 2019Completed
Condition(s):Chronic Ischemic Left Ventricular Dysfunction; Myocardial InfarctionLast Updated:October 22, 2020Withdrawn
Condition(s):Obesity; Morbid Obesity; Venous Thromboembolism; Atrial Fibrillation; Angina; Chest PainLast Updated:May 14, 2013Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.